Abbreviated rating score for Parkinson's disease

Area of Science:

• Neurology
• Clinical Neuroscience

Background:

• Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting motor function.
• Understanding the prevalence and correlates of specific symptoms is crucial for patient management.

Purpose of the Study:

• To investigate the characteristics and associated factors of various symptoms in a cohort of Parkinson's disease patients.
• To analyze the relationship between symptom severity, disease duration, and L-dopa treatment parameters.

Main Methods:

• A cross-sectional study of 240 Parkinson's disease patients.
• Assessment of motor and non-motor symptoms using a 0-4 rating scale (max score 24) and Hoehn and Yahr staging.
• Analysis of disease duration, L-dopa treatment duration and dosage, and occurrence of fluctuation, dyskinesia, psychosis, depression, and dementia.

Main Results:

• Fluctuation (42.9%), dyskinesia (7.1%), psychosis (9.6%), depression (4.6%), and dementia (2.9%) were observed.
• Longer PD duration was significantly associated with fluctuation, dyskinesia, and psychosis.
• Patients with fluctuation or dyskinesia received higher L-dopa doses and had longer treatment durations.
• Dementia was associated with a later age of onset.
• Symptom scores correlated with Hoehn and Yahr staging and were worse in patients with fluctuation, dyskinesia, psychosis, and dementia.

Conclusions:

• Symptom fluctuations, dyskinesia, and psychosis are significant indicators of disease progression and treatment intensity in Parkinson's disease.
• Age of onset may influence the development of dementia in PD patients.
• The findings highlight the importance of monitoring these specific symptoms for effective Parkinson's disease management.